CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- 4 Shares withheld for taxes Director gave up 224 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chairman & CEO sold 10,000 shares at an average $129.16 ($1,291,608)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Regulation FD disclosure · Other events
- SC TO-T/A Deal Tender Offer Statement
- SC TO-T/A Deal Tender Offer Statement
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $140.96 ($422,880)
- 4 Planned sale Chief Comm & Corp Aff Officer sold 3,000 shares at $140.96 ($422,880)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC TO-T/A Deal Tender Offer Statement
- 4 Planned sale Chairman & CEO sold 10,000 shares at $136.82 ($1,368,162)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
Page 5 of 160 · 3,186 filings